Honeywell International (NYSE:HON)- Reviving Stocks in Expert’s Opinion: The Timken Company (NYSE:TKR)

Honeywell International Inc. (NYSE:HON) [Trend Analysis] climbed reacts as active mover, shares a gain 1.52% to traded at $118.53 and the percentage gap between open changing to regular change was 0.15%.  Honeywell (NYSE: HON) will issue its fourth quarter and full year 2016 financial results before the opening of The New York Stock Exchange on Friday, January 27. The company will also hold a conference call with investors at 9:30 a.m. EST.

Lets us look over what analysts have to say about performance of the HON. Starting with EPS for the final quarter of this year. EPS is usually the indicator of profitability for the company. According to WSJ analysis, the Q4 2016 current estimates trends were for $1.74 as compared to the next year Q1 current trend of $1.62. While on annual basis the current EPS estimates trend for FY 2017 came in for $7.03 as compared to three months ago $7.09.

The stock prices target chart showed high target of 142.00 kept by analysts at WSJ while the average price target was for 128.57 as compared to current price of 118.53. Somehow, the stock managed to gain BUY ratings by 14 analysts in current tenure as 4 analysts having overweight ratings, 6 recommend as HOLD, 0 stands at Underweight. Overall, the consensus ratings were for Overweight by the pool of analysts.

The firm’s current ratio calculated as 1.20 for the most recent quarter. The firm past twelve months price to sales ratio was 2.30 and price to cash ratio remained 10.50. As far as the returns are concern, the return on equity was recorded as 26.70% and return on investment was 16.00% while its return on asset stayed at 9.70%. The firm has total debt to equity ratio measured as 0.83.

The Timken Company (NYSE:TKR) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 1.57% to $42.15. Finally to see some strong financial remarks by WSJ over TKR performance. Out of the pool of analysts 4 gave their BUY ratings on the stock in previous month as 3 analysts having BUY in current month. Majority ranked Overweight from the pool of analysts.

The next year first quarter EPS estimates trend for current period shows $0.45 while one month ago this estimate trend was for $0.45. EPS indicator shows the robustness of the stock and its analysis opens up the clear picture of company’s profitability. On annual basis of EPS, FY 2017 Estimate Trends at current were for $2.03 and for the one month was for $2.02 as compared to three months ago was for $2.09. Whereas, TKR received highest price target of 50.01 and low target of 32.00. The stock price target chart showed average price target of 40.67 as compared to current price of 42.15.

The share price of TKR attracts active investors, as stock price of week volatility recorded 2.36%. The stock is going forward to its 52-week low with 95.62% and lagging behind from its 52-week high price with 0.01%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *